Jpmorgan Chase & Co »

Lenz Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $135k 5.7k 23.74
2024-06-30 $94k 5.4k 17.29
2024-03-31 $38k 1.7k 22.33